National Stem Cell, Inc. Intends to Merge with Azurel, Ltd.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- National Stem Cell, Inc (NSCI NSCI No Significant Cost Impact ) today announced that it has entered into a letter of intent to merge with Azurel, Ltd. (AZUR.PK). Upon the completion of the merger, NSCI shareholders will own more than 90% of the outstanding shares of the surviving entity which will be called National Stem Cell, Inc. The letter of intent is a non-binding indication of the parties to merge and is subject to further due diligence by both parties. The parties intend to enter into a definitive merger agreement within 60 business days. About National Stem Cell, Inc. National Stem Cell, Inc. (NSCI) is a biotechnology company headquartered in Mountainside, New Jersey Mountainside is a borough in Union County, New Jersey, United States. As of the United States 2000 Census, the borough population was 6,602. Mountainside was incorporated as a borough on September 25, 1895, from portions of Westfield Township, based on the results of a dedicated to the advancement of regenerative medicine. Incorporated in 2005, NSCI is allied with a local laboratory and cryo-storage facility through a joint venture with Biogenetics Inc. and operates the Sperm Bank of New York as a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. . Through its sponsored research agreement with the Johns Hopkins University Johns Hopkins University, mainly at Baltimore, Md. Johns Hopkins in 1867 had a group of his associates incorporated as the trustees of a university and a hospital, endowing each with $3.5 million. Daniel C. School of Medicine's Institute for Cellular Engineering (ICE), NSCI is focused on the development of potential stem cell therapies for the treatment of diabetes and cardiac injury. The company also plans to develop a genetically diverse national umbilical cord blood umbilical cord blood Transplantation A source of primitive and stem cells that can be used to reconstitute BM destroyed by aplastic anemia or by RT or chemotherapy for CA, lymphoproliferative malignancies. See Bone marrow transplantation, Stem cell therapy. bank to meet the growing need for transplant grade umbilical cord blood stem cells. About Azurel Azurel Ltd., headquartered in New York, is a cosmetic company with its own proprietary brands including Privilege and Benendre. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion